Literature DB >> 31496610

Efficacy and Safety of Lateral Approach-Video Endoscopic Inguinal Lymphadenectomy (L-VEIL) over Open Inguinal Block Dissection: a Retrospective Study.

Sandeep P Nayak1, Harshwardhan Pokharkar2, Jaiprakash Gurawalia2, Kapil Dev2, Srinivas Chanduri2, M Vijayakumar3.   

Abstract

This retrospective study compared the immediate post-operative short-term outcomes of Lateral Approach-Video Endoscopic Inguinal Lymphadenectomy (L-VEIL) and open surgery approach in patients with TNM stage N0 and N1 tumors. Inguinal lymphadenectomies performed for various TNM stage N0 and N1 cancers between January 2011 and December 2015 at a single center were analyzed by collecting data from operation theater records and case files. Mean blood loss, operative time, drain output, nodal yield, nodal positivity, and complications were analyzed as post-procedural outcomes. Among the 116 surgeries performed, 92 were open surgery and 24 were L-VEIL. Compared with open surgery, L-VEIL led to significantly lower blood loss (64.8 mL vs. 23.3 mL; p = 0.002), mean nodal yield (11.04 vs. 8.38; p = 0.001), and mean hospital stay (3.08 vs. 8 days; p < 0.001). However, the operative time was similar for both the groups (94.5 vs. 68.1 min; p = 0.08). Complications that were significantly low in L-VEIL were flap necrosis [RR 1.29; 95% CI (1.03-1.72); p < 0.001], wound dehiscence [RR 1.25; 95% CI (1.19-1.51); p = 0.005), wound infection [RR 1.34; 95% CI (1.19-1.51); p = 0.003], readmission [RR 1.3; 95% CI (1.17-1.44); p = 0.005], and re-surgery [p = 0.014]. Occurrence of complications such as lymphocele [RR 1.25; 95% CI (0.33-4.78); p = 0.5], lymphorrhea [RR 1.27; 95% CI (1.15-1.40); p = 0.5], and pedal edema [p = 0.2] were similar for both the approaches. L-VEIL was effective and safe compared with open inguinal block dissection in treatment of various TNM stage N0 and N1 urogenital and skin cancers.

Entities:  

Keywords:  Inguinal block dissection; Lateral approach-video endoscopic inguinal lymphadenectomy (L-VEIL); Melanoma; Penile cancer; Vulvar cancer

Year:  2019        PMID: 31496610      PMCID: PMC6708014          DOI: 10.1007/s13193-019-00951-4

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  41 in total

1.  Videoscopic argon beam coagulator treatment of large persistent lymphocele.

Authors:  J H Crabtree; A Fishman
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2000-02       Impact factor: 1.878

Review 2.  Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection.

Authors:  S Horenblas
Journal:  BJU Int       Date:  2001-09       Impact factor: 5.588

3.  Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.

Authors:  Benjamin M Martin; Joanna W Etra; Maria C Russell; Monica Rizzo; David A Kooby; Charles A Staley; Viraj A Master; Keith A Delman
Journal:  J Am Coll Surg       Date:  2013-12-24       Impact factor: 6.113

4.  Robotic-Assisted Video Endoscopic Inguinal Lymphadenectomy in Carcinoma Vulva: Our Experiences and Intermediate Results.

Authors:  Vandana Jain; Rupinder Sekhon; Shveta Giri; Nahida Hassan; Kanika Batra; Swati H Shah; Sudhir Rawal
Journal:  Int J Gynecol Cancer       Date:  2017-01       Impact factor: 3.437

5.  Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia: a retrospective analysis in patients with malignant melanoma AJCC stage III.

Authors:  I Stoffels; J Dissemond; A Schulz; U Hillen; D Schadendorf; J Klode
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03-17       Impact factor: 6.166

6.  Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.

Authors:  Surena F Matin; Janice N Cormier; John F Ward; Louis L Pisters; Christopher G Wood; Colin P N Dinney; Richard E Royal; Xuelin Huang; Curtis A Pettaway
Journal:  BJU Int       Date:  2013-04-02       Impact factor: 5.588

7.  Video Endoscopic Inguinal Lymphadenectomy vs Open Inguinal Lymphadenectomy for Carcinoma Penis: Expanding Role and Comparison of Outcomes.

Authors:  Sher Singh Yadav; Vinay Tomar; Rohit Bhattar; Amit Kumar Jha; Shivam Priyadarshi
Journal:  Urology       Date:  2017-11-16       Impact factor: 2.649

8.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

9.  Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients?

Authors:  Marcos Tobias-Machado; Alessandro Tavares; Matheus Neves Ribeiro Silva; Wilson Rica Molina; Pedro Hermínio Forseto; Roberto Vaz Juliano; Eric Roger Wroclawski
Journal:  J Endourol       Date:  2008-08       Impact factor: 2.942

10.  Video endoscopic inguinal lymphadenectomy for radical management of inguinal nodes in patients with penile squamous cell carcinoma.

Authors:  Rajeev Chaudhari; Shahil Rameshbhai Khant; Dipen Patel
Journal:  Urol Ann       Date:  2016 Jul-Sep
View more
  2 in total

Review 1.  Minimal invasive approaches in lymph node management of carcinoma of penis: A review.

Authors:  Shreedhar Gurunathan Kandasamy; Kosur Ravi Chandran; Ginil Kumar Pooleri
Journal:  Indian J Urol       Date:  2022-01-01

2.  Comparison of the two routes of video endoscopic inguinal lymphadenectomy in vulvar cancer: a systematic review and a single-center experience.

Authors:  Lixia Luan; Rui Chen; Yang Yang; Fangfang Xue; Wenying Wang
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.